2-Chloro-2-phenyl-N-(thiazol-2-yl)acetamide

Catalog No.: 
ACNXMT922
CAS No.: 
116201-01-5
Molecular Formula: 
C11H9ClN2OS
Molecular Weight: 
252.73
2-Chloro-2-phenyl-N-(thiazol-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-2-phenyl-N-(thiazol-2-yl)acetamide
IUPAC Name2-chloro-2-phenyl-N-(thiazol-2-yl)acetamide
Molecular FormulaC11H9ClN2OS
Molecular Weight252.73
SMILESO=C(C(C1=CC=CC=C1)Cl)NC2=NC=CS2
InChI KeyBDBCWILLJCUQQW-UHFFFAOYSA-N
Synonym2-Chloro-2-phenyl-N-1,3-thiazol-2-ylacetamide;2-chloro-2-phenyl-N-(1,3-thiazol-2-yl)ethanamide;2-chloro-2-phenyl-N-(2-thiazolyl)acetamide;2-chloro-2-phenyl-N-thiazol-2-yl-acetamide;STK293598;Benzeneacetamide, α-chloro-N-2-thiazolyl-
CAS No.116201-01-5

Synthetic Route by SureRoute

1. ACNXMT922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8In Stock
  2. Plus
  3. ACGCPQ065 route compound structure diagram
    ACGCPQ0654755-72-0In Stock
  4. Then
  5. ACNXMT922 route product structure diagram
    ACNXMT922116201-01-5
Inquiry

2. ACNXMT922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8In Stock
  2. Plus
  3. ACWGSJ026 route compound structure diagram
    ACWGSJ0262912-62-1In Stock
  4. Then
  5. ACNXMT922 route product structure diagram
    ACNXMT922116201-01-5
Inquiry

3. ACNXMT922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNETC081 route compound structure diagram
    ACNETC0817476-66-6In Stock
  2. Plus
  3. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8In Stock
  4. Then
  5. ACNXMT922 route product structure diagram
    ACNXMT922116201-01-5
Inquiry

Comments (0)